Skip to main content
Year archive

Optipharm.CO.,LTD — 2021 filings

All 24 regulatory filings released by Optipharm.CO.,LTD (153710) in 2021, sourced directly from the official regulator.

24 Filings
2021 Period
2021 filings (24)
Filing Released Lang
주주명부폐쇄기간또는기준일설정
Regulatory Filings
2021-12-16 Korean
임원ㆍ주요주주특정증권등소유상황보고서
Director's Dealing
2021-12-07 Korean
주식등의대량보유상황보고서(일반)
Major Shareholding Notification
2021-12-07 Korean
기타경영사항(특허권취득)(자율공시)
Regulatory Filings
2021-12-01 Korean
대표이사변경
Board/Management Information
2021-11-30 Korean
[기재정정]주식매수선택권부여에관한신고
Share Issue/Capital Change
2021-11-30 Korean
임원ㆍ주요주주특정증권등소유상황보고서
Director's Dealing
2021-11-26 Korean
분기보고서 (2021.09)
Interim / Quarterly Report 9M 2021
2021-11-12 Korean
반기보고서 (2021.06)
Interim / Quarterly Report H1 2021
2021-08-13 Korean
임원ㆍ주요주주특정증권등소유상황보고서
Director's Dealing
2021-07-30 Korean
[기재정정]사업보고서 (2020.12)
Annual Report FY 2020
2021-06-03 Korean
분기보고서 (2021.03)
Interim / Quarterly Report Q1 2021
2021-05-14 Korean
[기재정정]분기보고서 (2021.03)
Interim / Quarterly Report Q1 2021
2021-05-14 Korean
임원ㆍ주요주주특정증권등소유상황보고서
Director's Dealing
2021-04-26 Korean
임원ㆍ주요주주특정증권등소유상황보고서
Director's Dealing
2021-04-26 Korean
임원ㆍ주요주주특정증권등소유상황보고서
Director's Dealing
2021-04-26 Korean
임원ㆍ주요주주특정증권등소유상황보고서
Director's Dealing
2021-03-29 Korean
정기주주총회결과
Declaration of Voting Results & Voting Rights Announcements
2021-03-24 Korean
사외이사의선임ㆍ해임또는중도퇴임에관한신고
Board/Management Information
2021-03-24 Korean
사업보고서 (2020.12)
Audit Report / Information FY 2020
2021-03-16 Korean
매출액또는손익구조30%(대규모법인은15%)이상변동
Earnings Release FY 2020
2021-03-09 Korean
주주총회소집결의
AGM Information
2021-03-09 Korean
주주총회소집공고
AGM Information
2021-03-09 Korean
감사보고서제출
Audit Report / Information FY 2020
2021-03-09 Korean